510(k) Report

510(k) · Cleared

Cleared

Powder Free Polyurethane Examination Gloves, Blue color, Tested for use with Chemotherapy Drugs

K222892510(k) TraditionalCleared Dec 15, 202283-day reviewClass I21 CFR 880.6250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Grand Work Plastic Products Co., Ltd. · LZA Polymer Patient Examination Glove

Cleared on Dec 15, 2022 as substantially equivalent to K203036 (Central Medicare Sdn Bhd, 2021) after an 83-day review. Its family tree reaches back 1 generation to 2021.

Decided
Dec 15, 2022
Review
83 days
Class
Class I
Product code
LZA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K203036 (2021). No later device cites it as a predicate yet.

  1. Root · 1 generation backK203036 Non Sterile Powder Free Polyurethane Examination Gloves (Blue and…Central Medicare Sdn Bhd · 2021
  2. This deviceK222892 Powder Free Polyurethane Examination Gloves, Blue color, Tested for…Grand Work Plastic Products Co., Ltd. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K203036Non Sterile Powder Free Polyurethane Examination Gloves (Blue and Black colors)Central Medicare Sdn Bhd2021—
0 (this device)K222892Powder Free Polyurethane Examination Gloves, Blue color, Tested for use with…Grand Work Plastic Products Co., Ltd.2022—
FIG. 1 — Lineage of K222892, 2021–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZA device

  1. #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K203036Non Sterile Powder Free Polyurethane Examination Gloves (Blue and Black colors)
Summary page 4
…, OPJ Device Class: Class I 3. Predicate Device Information: Central Medicare Sdn Bhd. Non Sterile Powder Free Polyurethane Examination Gloves (Blue and Black colors)- (K203036) Reference device: Inner Mongolia Cureguard Medical Technology Co.,Ltd. Disposable Nitrile Examination Glove (Tested for use wit…
Central Medicare Sdn Bhd2021—
†K222642Disposable Nitrile Examination Glove (Tested for use with Chemotherapy Drug)Inner Mongolia Cureguard Medical Technology Co., Ltd.2022—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All LZA devices

LZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · LZA

24in 2025

2007: 212008: 182009: 282010: 312011: 262012: 332013: 202014: 272015: 202016: 302017: 442018: 222019: 252020: 302021: 1392022: 1462023: 622024: 302025: 242026 (partial year): 15
2007high 146 (2022) · low 18 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZA

110in 2025

2007: 95 days median2008: 97 days median2009: 112 days median2010: 97 days median2011: 122 days median2012: 110 days median2013: 130 days median2014: 197 days median2015: 112 days median2016: 171 days median2017: 124 days median2018: 178 days median2019: 212 days median2020: 101 days median2021: 111 days median2022: 111 days median2023: 92 days median2024: 89 days median2025: 110 days median2026 (partial year): 103 days median
2007high 212 (2019) · low 89 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZA

3so far in 2026, the most since 2007

2015: 12016: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZA

73in 2025

2007: 72008: 22009: 122010: 122011: 92012: 112013: 102014: 82015: 122016: 252017: 42018: 32019: 212020: 42021: 202022: 192023: 242024: 762025: 73
2007high 76 (2024) · low 2 (2008)2025

MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007219507
2008189702
200928112012
20103197012
20112612209
201233110011
201320130010
20142719708
201520112112
201630171125
20174412404
20182217803
201925212021
20203010104
2021139111020
2022146111019
20236292024
20243089076
202524110073
2026151033—

What is it indicated for?

The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs using ASTM D6978-05(2019) Chemotherapy Drug Minimum Breakthrough Detection Time (BDT) in Minutes Carmustine 3.3 mg/ml (3,300 ppm) 24.0 Cisplatin 1mg/ml (1,000 ppm) >240 Cyclophosphamide 20mg/ml (20,000 ppm) >240 Dacarbazine 10 mg/ml (10,000 ppm)…

Read the full statement (122 words)

The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs using ASTM D6978-05(2019)

Chemotherapy Drug Minimum Breakthrough Detection Time (BDT) in Minutes

Carmustine 3.3 mg/ml (3,300 ppm) 24.0

Cisplatin 1mg/ml (1,000 ppm) >240

Cyclophosphamide 20mg/ml (20,000 ppm) >240

Dacarbazine 10 mg/ml (10,000 ppm) >240

Doxorubicin HCL, 2 mg/ml (2,000 ppm) >240

Etoposide, 20 mg/ml (20,000 ppm) >240

Fluorouracil, 50mg/ml (50,000ppm) >240

Methotrexate, 25mg/ml (25,000ppm) >240

Paclitaxel, 6mg/ml (6,000ppm) >240

Thiotepa, 10mg/ml (10,000ppm) 0.6

* Please note that the following drugs have extremely low permeation times:

Carmustine: 24.0 minutes, Thiotepa: 0.6 minutes

Warning: Do not use with Carmustine or Thiotepa.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K222892: Powder Free Polyurethane Examination Gloves, Blue color, Tested for use with Chemotherapy Drugs.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K222892

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026